Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).
NCT05664113 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2026-05-19
Summary
The study participant is being asked to take part in this clinical trial, a type of research study, because the participant has Gastrointestinal (GI) symptoms following a Hematopoietic Cell Transplant (HCT).
Primary Objective
* To determine the safety and feasibility of FMT for treating a GvHD of the gut following HCT.
* To determine the safety and feasibility of FMT for treating HCT induced gut dysfunction.
Secondary Objectives
* To assess the potential efficacy of FMT for treating a GvHD of the gut following HCT.
* To assess the potential efficacy of FMT for treating HCT induced gut dysfunction.
Conditions
- Gastro-Intestinal Disorder
Interventions
- DRUG
-
Fecal microbiota transplant (FMT)
FMT Lower Delivery Microbiota Preparation, Dose: 250 mL of Microbiota Preparation Material and Route of administration: colonoscopy FMT Upper Delivery Microbiota Preparation, Dose: 60 mL of Microbiota Preparation Material and Route of administration: Naso-enteral tube
Sponsors & Collaborators
-
St. Jude Children's Research Hospital
lead OTHER
Principal Investigators
-
Gabriela Maron, MD · St. Jude Children's Research Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-07
- Primary Completion
- 2026-12-31
- Completion
- 2028-12-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
FMT for Steroid Resistant Gut Acute GVHD
NCT04285424 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Fecal Microbiota Transplantation in aGvHD After ASCT
NCT03819803 ·Status: RECRUITING ·Phase: PHASE3
-
Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products
NCT05713214 ·Status: RECRUITING
-
Gut Decontamination In Pediatric Allogeneic Hematopoietic
NCT02641236 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Transplantation for Steroid Resistant and Steroid Dependent Gut Acute Graft Versus Host Disease
NCT03214289 ·Status: UNKNOWN ·Phase: PHASE1
-
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
NCT02398708 ·Status: COMPLETED
-
Prophylaxis Roles of IL-2 Treatment on GVHD After Transplantation
NCT02659657 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
NCT04629430 ·Status: COMPLETED ·Phase: NA
-
Intervention for Fatigue in HCT Recipients
NCT05715047 ·Status: RECRUITING ·Phase: NA
-
The Association of Microbiota Composition With cGVHD After Allo-HSCT
NCT05355675 ·Status: UNKNOWN
-
Multimodal Sexual Dysfunction Intervention In HCT
NCT03803696 ·Status: COMPLETED ·Phase: NA
-
Clinical Outcomes, Nutritional Status, Exercise and Psychosocial Factors in Pediatric Hematopoietic Cell Transplant
NCT02734797 ·Status: COMPLETED
-
Microbiome Alterations in IL10RA-deficient Patients After HSCT
NCT03752372 ·Status: TERMINATED
-
Fecal Microbiota Transplantation Among Adult Patients With Hematological Malignancies
NCT07172191 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell Transplant Recipients
NCT02403089 ·Status: COMPLETED
-
Long Term Follow-Up Study for Individuals With Hemoglobin Disorders After Hematopoietic Cell Transplant or Gene Therapy
NCT06646640 ·Status: RECRUITING
-
A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).
NCT05090345 ·Status: RECRUITING
-
Enteral Nutrition Versus Standard of Care in Allogeneic Hematopoietic Stem Cell Transplantation
NCT07315165 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study on Intelligent Nutrition Support Therapy for Hematopoietic Stem Cell Transplantation Recipients
NCT05590091 ·Status: UNKNOWN ·Phase: NA
-
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
NCT00002673 ·Status: COMPLETED ·Phase: PHASE2
-
Preemptive Therapy With CMV-specific T Cells Infusion to Prevent Refractory CMV Infection Post Transplantation
NCT02985775 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
NCT03128996 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Dysbiosis and Immune Reconstitution After Allo-HSCT
NCT03616015 ·Status: UNKNOWN ·Phase: NA
-
Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010
NCT03111745 ·Status: COMPLETED
-
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
NCT02598752 ·Status: COMPLETED